Radiation therapy for pediatric central nervous system tumors

Journal of Child Neurology

Volumn 24, Issue 11, 2009, Pages 1387-1396

  Hoffman, Karen E ^a   Yock, Torunn I ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Primary central nervous system neoplasms; Proton radiation; Radiotherapy

Indexed keywords

CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM TUMOR; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CRANIOPHARYNGIOMA; EPENDYMOMA; FATIGUE; GERM CELL TUMOR; HAIR LOSS; HEADACHE; HEARING IMPAIRMENT; HUMAN; INTELLIGENCE QUOTIENT; LONG TERM CARE; MEDULLOBLASTOMA; MORBIDITY; NEUROENDOCRINE DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE; SKIN REDNESS; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; TARGET ORGAN;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; HUMANS; RADIOTHERAPY; SPINAL NEOPLASMS;

EID: 70449115248     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073809342275     Document Type: Conference Paper

References (31)

1. Khan F. The physics of radiation therapy. 3rd ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2003.
2. Hall EJ, Giaccia AJ Chapter 2: DNA strand breaks and chromosomal aberrations. In: Radiobiology for the Radiologist. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006:16-29.
3. Hall EJ, Giaccia AJ Chapter 5: Repair of radiation damage and the dose-rate effect. In: Radiobiology for the Radiologist. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2006:60-84.
4. Merchant TE, Kiehna EN, Li C., Xiong X., Mulhern RK Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys. 2005;63(5):1546-1554.
5. Wefel JS, Witgert ME, Meyers CA Neuropsychological sequelae of non-central nervous system cancer and cancer therapy. Neuropsychol Rev. 2008;18(2):121-131.
6. Beebe DW, Ris MD, Armstrong FD, et al. Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: Evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies (CCG 9891/POG 9130). J Clin Oncol. 2005;23(22):5198-5204.
7. Hua C., Bass JK, Khan R., Kun LE, Merchant TE Hearing loss after radiotherapy for pediatric brain tumors: Effect of cochlear dose. Int J Radiat Oncol Biol Phys. 2008;72(3):892-899.
8. Heikens J., Michiels EM, Behrendt H., Endert E., Bakker PJ, Fliers E. Long-term neuro-endocrine sequelae after treatment for childhood medulloblastoma. Eur J Cancer. 1998;34(10):1592-1597.
9. Hawkins MM Long-term survivors of childhood cancers: What knowledge have we gained ? Nat Clin Pract Oncol. 2004;1(1):26-31.
10. Xu W., Janss A., Moshang T. Adult height and adult sitting height in childhood medulloblastoma survivors. J Clin Endocrinol Metab. 2003;88(10):4677-4681.
11. Liu AK, Bagrosky B., Fenton LZ, et al. Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy. Pediatr Blood Cancer. 2009;52(2):227-230.
12. Desai SS, Paulino AC, Mai WY, Teh BS Radiation-induced moyamoya syndrome. Int J Radiat Oncol Biol Phys. 2006;65(4):1222-1227.
13. Broniscer A., Ke W., Fuller CE, Wu J., Gajjar A., Kun LE Second neoplasms in pediatric patients with primary central nervous system tumors: The St. Jude Children's Research Hospital experience. Cancer. 2004;100(10):2246-2252.
14. Neglia JP, Robison LL, Stovall M., et al. New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2006;98(21):1528-1537.
15. Reddy AT, Packer RJ Chemotherapy for low-grade gliomas. Childs Nerv Syst. 1999;15(10):506-513.
16. Packer RJ, Goldwein J., Nicholson HS, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol. 1999;17(7):2127-2136.
17. Wolden SL, Dunkel IJ, Souweidane MM, et al. Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. J Clin Oncol. 2003;21(16):3079-3083.
18. St Clair WH, Adams JA, Bues M., et al. Advantage of protons compared to conventional X-ray or IMRT in the treatment of a pediatric patient with medulloblastoma. Int J Radiat Oncol Biol Phys. 2004;58(3):727-734.
19. Hall EJ Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65(1):1-7.
20. Gerweck L., Paganetti H. Chapter 2: Radiobiology of charged particles. In: Delaney TF, Kooy HM, eds. Proton and Charged Particle Radiotherapy. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:8-18.
21. Gottschalk B. Chapter 5: Treatment delivery systems. In: Delaney TF, Kooy HM, eds. Proton and Charged Particle Radiotherapy. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:33-49.
22. Gottschalk B. Chapter 8: Treatment planning. In: Delaney TF, Kooy HM, eds. Proton and Charged Particle Radiotherapy. Philadelphia, PA: Lippincott Williams and Wilkins; 2008:70-107.
23. Suit H., Kooy H., Trofimov A., et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Radiother Oncol. 2008;86(2):148-153.
24. Merchant TE, Hua CH, Shukla H., Ying X., Nill S., Oelfke U. Proton versus photon radiotherapy for common pediatric brain tumors: Comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer. 2008;51(1):110-117.
25. MacDonald SM, Safai S., Trofimov A., et al. Proton radiotherapy for childhood ependymoma: Initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys. 2008;71(4):979-986.
26. Yock T., Schneider R., Friedmann A., Adams J., Fullerton B., Tarbell N. Proton radiotherapy for orbital rhabdomyosarcoma: Clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys. 2005;63(4):1161-1168.
27. Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: How do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 2005;63(2):362-372.
28. Kozak KR, Adams J., Krejcarek SJ, Tarbell NJ, Yock TI A dosimetric comparison of proton and intensity-modulated photon radiotherapy for pediatric parameningeal rhabdomyosarcomas. Int J Radiat Oncol Biol Phys. 2009;74(1):179-186.
29. Fuss M., Hug EB, Schaefer RA, et al. Proton radiation therapy (PRT) for pediatric optic pathway gliomas: Comparison with 3D planned conventional photons and a standard photon technique. Int J Radiat Oncol Biol Phys. 1999;45(5):1117-1126.
30. Yock T., Bolle S., Pulsifer M., et al. Clinical outcomes of proton radiation therapy for pediatric low-grade gliomas. Neuro Oncol. 2008;10(3):497.
31. Chung CS, Keating N., Yock T., Tarbell N. Comparative analysis of second malignancy risk in patients treated with proton therapy versus conventional photon therapy. Int J Radiat Oncol Biol Phys. 2008;72(suppl 1):S8.